Home
NICE Guidance
Published Guidance

Everolimus for the second-line treatment of advanced renal cell carcinoma

Technology appraisal guidance [TA219] Published: 19 April 2011

Guidance

This guidance has been updated and replaced by NICE technology appraisal guidance 432.